The chairman of Medicon Valley Alliance, Søren Bregenholt´s quarterly business column in Copenhagen Post “The Valley of Life: All for one and one for all” has just been published. Read why MVA thinks life science in the Nordics in general and in Denmark and Sweden in particular should preferably adopt a more “All for one and one for all”- approach.
MVA member Lund-based Asgard Therapeutics announces €30 million Series A financing to advance its first-in-class in vivo cell reprogramming platform for immuno-oncology
On the 14 March 2024 Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy,...